ArticleCancers2022
CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer.
Bin Lan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleCancers2022
Bin Lan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.